Global Market Research Report on Epilepsy Drug Market 2017 is a professional and in-depth complete study on the current state of the Epilepsy Drug worldwide.

Deerfield Beach, FL -- (SBWire) -- 04/10/2017 --Latest industry research report on Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure. It is one of the most common neurological disorders worldwide, affecting people of all ages. Presently, around 50 million patients are living with epilepsy worldwide and about 2.4 million new cases are diagnosed annually. Moreover, majority of the epileptic cases are idiopathic, with no identifiable cause. At present, only symptomatic treatment through medication, surgery and implantable devices, is available, but there is no cure for epilepsy. This highlights the untapped market need for better therapeutics which would provide lucrative growth opportunities to industry players.

Rising incidence of neurological disorders, higher incidence of birth related injuries, increasing road traffic injuries, growing disease awareness and rising patient base in developing countries, are the significant factors driving the global antiepileptic drug market.

Get Free Sample Report Of Epilepsy Market @ http://www.marketresearchstore.com/report/world-epilepsy-drug-market-opportunities-and-forecasts-71723#RequestSample

Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Collaboration and new product approval are some of the key strategies adopted by leading industry players. In July 2014, Intellimedix entered into research collaboration with Pfizer and The Epilepsy Foundation, for preclinical testing of an experimental drug. Sunovion Pharmaceuticals Inc., in Nov 2013, got FDA marketing approval for epilepsy drug Aptiom (eslicarbazepine acetate) for treatment of partial seizures.

Do Inquiry To Buy Report Of Epilepsy Market @ http://www.marketresearchstore.com/report/world-epilepsy-drug-market-opportunities-and-forecasts-71723#InquiryForBuying

The global Epilepsy Drug market is segmented below:

Epilepsy Drug Market By Drug Type

Marketed Drugs
First Generation Drugs

Phenytoin
Carbamazepine
Oxycarbazepine
Valproate
Ethosuximide
Primidone
Phenobarbital

Second Generation Drugs

Levetiracetam
Lamotrigine
Topiramate
Pregabalin
Rufinamide
Zonisamide

Third Generation Drugs

Lacosamide
Perampanel
Eslicarbazepine Acetate
Ezogabine/Retigabine
Pipeline Drugs

Epilepsy Drug Market By Geography

North America
Europe
AsiaPacific
LAMEA

About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: 386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/